Literature DB >> 30475949

Risk-Set Matching to Assess the Impact of Hospital-Acquired Bloodstream Infections.

David Watson1, Alicen B Spaulding1, Jill Dreyfus2.   

Abstract

Hospital-acquired bloodstream infections have a definite impact on patient encounters and cause increased length of stay, costs, and mortality. However, methods for estimating these effects are potentially biased, especially if the time of infection is not incorporated into the estimation strategy. We focused on matching patient encounters in which a hospital-acquired infection occurred to comparable encounters in which an infection did not occur. This matching strategy is susceptible to a selection bias because inpatients that stay longer in the hospital are more likely to acquire an infection and thus also are more likely to have longer and more costly stays. Instead, we have proposed risk-set matching, which matches infected encounters to similar encounters still at risk for infection at the corresponding time of infection. Matching on the one-dimensional propensity score can create comparable pairs for a large number of characteristics; an analogous propensity score is described for risk-set matching. We have presented dramatically different estimates using these 2 approaches with data from a pediatric cohort from the Premier Healthcare Database, United States, 2009-2016. The results suggest that estimates that did not incorporate time of infection exaggerated the impact of hospital-acquired infections with regard to attributed length of stay and costs.

Entities:  

Mesh:

Year:  2019        PMID: 30475949     DOI: 10.1093/aje/kwy252

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  7 in total

1.  Escaping mechanisms of ESKAPE pathogens from antibiotics and their targeting by natural compounds.

Authors:  Ragi Jadimurthy; Shilpa Borehalli Mayegowda; S Chandra Nayak; Chakrabhavi Dhananjaya Mohan; Kanchugarakoppal S Rangappa
Journal:  Biotechnol Rep (Amst)       Date:  2022-04-04

2.  Bloodstream Infections in the Intensive Care Unit: a Single-Center Retrospective Bacteriological Analysis Between 2007 and 2019.

Authors:  Aneta Guzek; Zbigniew Rybicki; Agnieszka Woźniak-Kosek; Dariusz Tomaszewski
Journal:  Pol J Microbiol       Date:  2022-06-19

3.  Effectiveness, safety and cost analysis of dalbavancin in clinical practice.

Authors:  Maria Arrieta-Loitegui; Jose Manuel Caro-Teller; Sara Ortiz-Pérez; Francisco López-Medrano; Rafael San Juan-Garrido; Jose Miguel Ferrari-Piquero
Journal:  Eur J Hosp Pharm       Date:  2020-10-05

4.  Evaluating the impact of the Bolsa Familia conditional cash transfer program on premature cardiovascular and all-cause mortality using the 100 million Brazilian cohort: a natural experiment study protocol.

Authors:  Julia M Pescarini; Peter Craig; Mirjam Allik; Leila Amorim; Sanni Ali; Liam Smeeth; Mauricio L Barreto; Alastair H Leyland; Estela M L Aquino; Srinivasa Vittal Katikireddi
Journal:  BMJ Open       Date:  2020-11-20       Impact factor: 3.006

5.  Risk Factors for a Hospital-Acquired Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infection: A Five-Year Retrospective Study.

Authors:  Zubai Cao; Chengcheng Yue; Qinxiang Kong; Yanyan Liu; Jiabin Li
Journal:  Infect Drug Resist       Date:  2022-02-25       Impact factor: 4.003

6.  The Impact of Nosocomial Bloodstream Infections on Mortality: A Retrospective Propensity-Matched Cohort Study.

Authors:  Neta Petersiel; Assa Sherman; Mical Paul
Journal:  Open Forum Infect Dis       Date:  2021-11-06       Impact factor: 3.835

7.  Estimating length of stay and inpatient charges attributable to hospital-acquired bloodstream infections.

Authors:  Yuzheng Zhang; Mingmei Du; Janice Mary Johnston; Ellie Bostwick Andres; Jijiang Suo; Hongwu Yao; Rui Huo; Yunxi Liu; Qiang Fu
Journal:  Antimicrob Resist Infect Control       Date:  2020-08-18       Impact factor: 4.887

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.